.jpg)
.png)
Last Updated: Friday, 05-Jun-2015 16:00:00 EDT
On June 3, 2015, the anticipated final results of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) was published online in the New England Journal of Medicine (NEJM 2015;372:2387-97).
Last Updated: Thursday, 02-Apr-2015 16:00:00 EDT
Emphasizes the Importance of LDL-Cholesterol Monitoring, LDL Goal Attainment and Shared Decision Making Between Patients and Provider
Last Updated: Thursday, 02-Apr-2015 16:00:00 EDT
The National Lipid Association (NLA) was in attendance at the recent American College of Cardiology (ACC) Annual Scientific Session and Expo 2015, March 14-16, in San Diego.
The Foundation of the National Lipid Association (FNLA) supports patient and clinician educational, research, and community outreach activities that enhance and support the initiatives of the NLA in its efforts to reduce cardiovascular events and deaths related to abnormalities of cholesterol metabolism.
Article By:
FOUNDATION OF NLA ANNUAL REPORT
Merle Myerson, MD, is a woman of many talents and a wearer of many hats. Her dedication to her work is more of a passion than a career, and according to her, it is her “vocation and avocation.” As founder and director of the Mount Sinai Roosevelt and St. Luke’s Cardiovascular Disease Prevention Program & Lipid Clinic, Pre-Exercise Heart Screening Program, and Cardiology Section in the Institute for Advanced Medicine HIV Clinic, as well as an attending cardiologist, Dr.
Article By:
MERLE MYERSON, MD, EdD, FACC, FNLA
Director, Mount Sinai Roosevelt and St. Luke's
Cardiovascular Disease Prevention Program & Lipid Clinic
Pre-Exercise Heart Screening Program
Cardiology Section, Institute for Advanced Medicine (HIV)
Cardiovascular Disease Prevention Program & Lipid Clinic
Pre-Exercise Heart Screening Program
Cardiology Section, Institute for Advanced Medicine (HIV)
“Tell me and I forget. Teach me and I remember. Involve me and I learn.” – Benjamin Franklin
Article By:
DANIEL SOFFER, MD, FNLA
Clinical Associate Professor of Medicine
University of Pennsylvania
Internal Medicine and Preventive Cardiology
University of Pennsylvania Health System
Philadelphia, PA
University of Pennsylvania
Internal Medicine and Preventive Cardiology
University of Pennsylvania Health System
Philadelphia, PA
Diplomate, American Board of Clinical Lipidology
Introduction
Article By:
KAREN E. ASPRY, MD, MS, ABCL, FACC
Director, Lipid and Prevention Program
Lifespan Cardiovascular Institute
Assistant Clinical Professor of Medicine
Brown University, Alpert Medical School
Providence, RI
Lifespan Cardiovascular Institute
Assistant Clinical Professor of Medicine
Brown University, Alpert Medical School
Providence, RI
Diplomate, American Board of Clinical Lipidology
It is well known that women are not protected from cardiovascular events but experience event rates at older ages equivalent to men after a 10-year lag time.
Article By:
SAMUEL S. GIDDING, MD
A.I. DuPont Hospital for Children
Chief, Pediatric Cardiology
Department of Pediatrics
Wilmington, DE
Chief, Pediatric Cardiology
Department of Pediatrics
Wilmington, DE
Coronary heart disease (CHD) is the leading cause of death of men and women in the world but in younger age groups, the CHD-related death rate is strikingly higher in men compared to women.1 Emerging evidence suggests that a disparity exists in regards to cardiovascular risks and outcomes among the sexes.
Article By:
SALEEM NAINA, PharmD, BCPS, CGP
Clinical Pharmacy Specialist
Albany, NY
Albany, NY
Cardiovascular disease affects one in three adult males and accounts for 25 percent of their mortality, making it the leading cause of death for men in the U.S.1,2 Clinical androgen deficiency, characterized by low testosterone levels with manifest symptoms, affects a large number of middle-aged and older men and can significantly impact not only quality of life but also several cardiovascular risk factors and mortality.
Article By:
MONIQUE S. TANNA, MD
Cardiovascular Disease Fellow
New York University School of Medicine
New York, NY
New York University School of Medicine
New York, NY
RODA PLAKOGIANNIS, PharmD, BCPS, CLS, FNLA
Associate Professor of Pharmacy Practice
Arnold & Marie Schwartz College of Pharmacy and Health Science
Long Island University
Brooklyn, NY
Clinical Primary Care Pharmacist, NYU Langone Medical Center
New York, NY
Arnold & Marie Schwartz College of Pharmacy and Health Science
Long Island University
Brooklyn, NY
Clinical Primary Care Pharmacist, NYU Langone Medical Center
New York, NY
Diplomate, Accreditation Council of Clinical Lipidology